Clinical Trial Update: China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype [Phase 4]

View source ↗

Summary

This clinical trial update notes the Phase 4 China Stroke Primary Prevention Trial 2, enrolling participants with hypertension and the MTHFR 677 TT genotype for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Stroke

Snippet

Sponsor: Shenzhen Ausa Pharmed Co.,Ltd | Conditions: Hypertension, MTHFR 677 TT Genotype | Phase 4 | Status: RECRUITING